Mayo Clinic scientists have developed a computational model that predicts brain age using a large collection of neuroimaging data obtained using FDG-PET (fluorodeoxyglucose positron emission tomography) and structural MRI (magnetic resonance imaging). The deep learning-based model tests the relationship between brain age gaps in various forms of dementia, including mild cognitive impairment (MCI), Alzheimer’s disease (AD), frontotemporal dementia (FTD), and Lewy body dementia (LBD), as well as in normal brains.
Quick heads-up about a great event next month for those based in the San Francisco Bay Area.
- When: Tuesday, September 17, 2019 / 8:30 AM – 6:00 PM PDT
- Where: Pauley Ballroom, UC Berkeley
- What: 2019 UC Berkeley Aging Research & Technology Summit: Disrupting Neurodegenerative Diseases
Alzheimer’s and neurodegenerative diseases are [Read more…] about September 17th @ UC Berkeley: Disrupting neurodegenerative diseases
“As we age, we often have problems with our ability to smell (called olfactory dysfunction). Older people might not be able to identify an odour or differentiate one odour from another. In some cases they might not be able to detect an odour at all.
Odour identification difficulties are common in people with neurodegenerative diseases, including Alzheimer’s disease [Read more…] about Study finds promise in smell training to harness neuroplasticity and improve brain health in older adults
Practice Imperfect: Repeated Cognitive Testing Can Obscure Early Signs of Dementia (UC San Diego Health press release):
“Alzheimer’s disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.
But in a paper published online in the journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, a team of researchers led by scientists at the University of California San Diego School of Medicine found that repeated testing of middle-age men produced a “practice effect” which obscured true cognitive decline and [Read more…] about Study: Practice effect due to repeated testing can delay detection of cognitive impairment and dementia
Why I’m Digging Deep Into Alzheimer’s (Bill Gates):
“In every part of the world, people are living longer than they used to. Thanks to scientific advancements, fewer people die young from heart disease, cancer, and infectious diseases. It’s no longer unusual for a person to live well into their 80s and beyond. My dad will celebrate his 92nd birthday in a couple weeks, a milestone that was practically unimaginable when he was born.
This fact—that people are living longer than ever before—should always be a wonderful thing. But what happens when it’s not? [Read more…] about Bill Gates announces $50 million investment to fight Alzheimer’s Disease
U.S. Patent No. 8,121,694: Therapy control based on a patient movement state
- Assignee(s): Medtronic, Inc.
- Inventor(s): Gregory F. Molnar, Steven S. Gill, Keith A, Miesel, Mark S. Lent, Timothy J. Denison, Eric J. Panken, Carl D. Wahlstrand, Jonathan C. Werder
- Technology Category: Neuro-monitoring
- Issue Date: February 21, 2012
The ‘694 patent discloses methods to treat patients afflicted with movement or other neurodegenerative disorders through brain-signal feedback. [Read more…] about Augmenting physiotherapy via neurofeedback and neurostimulation: Key neurotechnology patent #43